Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) announced its quarterly earnings results on Monday. The company reported $0.06 earnings per share for the quarter, hitting the consensus estimate of $0.06, Bloomberg Earnings reports. The business had revenue of $29.70 million during the quarter, compared to analysts’ expectations of $27.84 million. The firm’s revenue was up 32.6% on a year-over-year basis.

Shares of Tabula Rasa Healthcare (TRHC) traded up 0.75% during midday trading on Monday, hitting $14.86. 44,300 shares of the stock traded hands. Tabula Rasa Healthcare has a 52-week low of $10.39 and a 52-week high of $16.85. The stock has a 50-day moving average of $14.64 and a 200-day moving average of $14.00. The company’s market cap is $255.86 million.

TRHC has been the subject of several research reports. Stifel Nicolaus reaffirmed a “buy” rating and issued a $16.00 price target on shares of Tabula Rasa Healthcare in a research report on Friday, July 14th. Zacks Investment Research raised shares of Tabula Rasa Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday, May 16th. UBS AG reaffirmed a “buy” rating and issued a $17.00 price target (down previously from $18.00) on shares of Tabula Rasa Healthcare in a research report on Thursday, May 25th. Finally, Chardan Capital initiated coverage on shares of Tabula Rasa Healthcare in a research report on Monday, July 10th. They issued a “buy” rating and a $19.50 price target for the company. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $17.25.

COPYRIGHT VIOLATION NOTICE: “Tabula Rasa Healthcare Inc. (TRHC) Releases Quarterly Earnings Results, Meets Expectations” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/07/tabula-rasa-healthcare-inc-trhc-releases-quarterly-earnings-results-meets-expectations.html.

In other Tabula Rasa Healthcare news, Director Glen R. Bressner acquired 7,500 shares of the company’s stock in a transaction that occurred on Thursday, May 18th. The stock was purchased at an average price of $11.96 per share, for a total transaction of $89,700.00. Following the completion of the acquisition, the director now owns 18,256 shares of the company’s stock, valued at approximately $218,341.76. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Gordon Tunstall sold 22,759 shares of Tabula Rasa Healthcare stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $13.76, for a total transaction of $313,163.84. Following the completion of the transaction, the director now owns 5,565 shares of the company’s stock, valued at approximately $76,574.40. The disclosure for this sale can be found here. Insiders sold 46,759 shares of company stock valued at $634,444 in the last 90 days. Company insiders own 45.80% of the company’s stock.

About Tabula Rasa Healthcare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.